Rimma Driscoll Named to Dexcom’s Board of Directors

DexCom Inc. has appointed Rimma Driscoll to its Board of Directors.
 
Driscoll has significant experience developing, guiding, and executing organic and inorganic growth strategies for global organizations. She currently serves as executive vice president and head of Global Strategy, Commercial and Business Development, and Global BioDevices for Zoetis, the world’s leading animal health company. In this role, Driscoll oversees the company’s global business strategy, the execution of commercial launch plans, external business development and integration efforts, and has oversight for Zoetis’ Global BioDevices business. She brings to the Dexcom board a track record of impactful leadership across the global healthcare, consumer and animal health industries, including the successful completion of several transformative transactions and key product launches.
 
“We are very excited to welcome Rimma to the Dexcom Board,” Dexcom Chairman, President, and CEO Kevin Sayer said. “Her strategic guidance at Zoetis and Procter & Gamble has been instrumental in helping these two global organizations achieve and grow their market leadership positions. As we continue to extend access to Dexcom’s real-time CGM systems to more people throughout the world, we look forward to benefiting from Rimma’s experience navigating global commercial markets and key strategic partnerships.”
 
Prior to assuming her role as a member of the Zoetis Executive Leadership Team last year, Driscoll was senior vice president and head of Global Business Development, Business Integrations, and Strategic Alliances from 2020 to 2022, and vice president and head of Global Business Development and Strategic Alliances for Zoetis from 2016 to 2020. Before joining Zoetis, Driscoll served in roles of increasing responsibility at Procter & Gamble from 1994 to 2016. She established and led the company’s global business development group in Geneva, Switzerland, during her tenure as executive global head for Europe, Corporate Global Business Development from 2012 to 2016.
 
Besides her current role at Zoetis, Driscoll is a board member for Pumpkin Insurance, a preventive care and pet insurance provider in which Zoetis has a minority stake. She earned a bachelor’s degree in chemistry from Bowling Green State University and an MBA from Xavier University.
 
DexCom empowers people to take real-time control of health through continuous glucose monitoring systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom develops diabetes care technology.